Возраст домена | 21 год |
Дата окончания | Истек срок регистрации |
PR | 6 |
ИКС | n/a |
Страниц в Google | 170000 |
Страниц в Яндексе | 496 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 2021939 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Commercial Partnerships | Cancer Research UK
n/a
n/a
UTF-8
125.52 КБ
2 500
26 734 симв.
22 959 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
64 | 8 |
0 | 113 | ![]() | |
![]() ![]() |
34 | 9 |
0 | 5 | ![]() | |
![]() ![]() |
28 | 8 |
0 | 20915 | ![]() | |
![]() ![]() |
21 | 7 |
30 | 37657 | ![]() | |
![]() ![]() |
18 | 9 |
0 | 740 | ![]() | |
![]() ![]() |
16 | 8 |
1200 | 5911 | ![]() | |
![]() |
12 | 6 |
30 | 1003814 | ![]() | |
![]() |
12 | 8 |
130 | 337231 | ![]() | |
![]() ![]() |
12 | 8 |
0 | 157672 | ![]() | |
![]() ![]() |
11 | 8 |
0 | 9304 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Ссылок в Alexa | 677 |
Данные linkpad ( 5 Марта 2013 ) | |
Количество ссылок на сайт | 247 |
Количество доменов, которые ссылаются на сайт | 92 |
Количество найденных анкоров | 71 |
Исходящие (внешние) ссылки домена | 24 |
Количество доменов, на которые ссылается сайт | 15 |
Количество исходящих анкоров | 15 |
Внешние ссылки главной страницы ( 11 ) | |
commercial.cancerresearchuk.org/our-company | Read more |
crtdiscoverylabs.com | Visit the CRUK-TDL website |
commercial.cancerresearchuk.org/licensing-opportunites | View our opportunities |
commercial.cancerresearchuk.org/have-idea | Get in touch |
twitter.com/CRT_News | Join us on Twitter |
cancertechnology.co.uk/our-network | <img> |
twitter.com/CRUKResearch | |
linkedin.com/showcase/cancer-research-uk-translation-&-comme... | |
cancerresearchuk.org/privacy-statement | Privacy Statement |
cancertechnology.co.uk/modern-slavery-statement | Modern Slavery Statement |
cancerresearchuk.org | www.cruk.org |
Внутренние ссылки главной страницы ( 196 ) | |
# | Back to top |
/our-approach | Our Approach |
/overview | Overview |
/our-people | Our People |
/our-network | <img> |
/history | History |
/services | Overview |
/project-development | Project Development |
/have-idea | Have an idea? |
/commercialisation | Commercialisation |
/drug-discovery | Drug Discovery |
/cruk-drug-discovery | CRUK Drug Discovery |
/clinical-development | Clinical Development |
/clinical-development-partnerships | CDP |
/imaging | Imaging |
/funding | Funding |
/our-projects | Overview |
/our-pipeline | Our Pipeline |
/licensing-opportunities | Licensing Opportunities |
/lo-small-molecules-search | Small Molecules |
/lo-biological-therapeutics-search | Biological Therapeutics |
/lo-enabling-technology-search | Enabling Technology |
/lo-biomarkers-search | Biomarkers |
/our-start-ups | Our Start-ups |
/research-tools | Research Tools |
news-and-events | Read more news |
/alliance-translational-research-centres-established-acceler... | Alliance of translational research centres established to accelerate global drug development |
/astex-pharmaceuticals-earns-54-m-milestone-phi-trial-initia... | Astex Pharmaceuticals Earns $5.4 M Milestone on PhI Trial Initiation of a FGFR Kinase Inhibitor |
/crt-adc-therapeutics-join-forces-antibody-drug-conjugates | CRT & ADC Therapeutics join forces on Antibody Drug Conjugates |
/crt-and-teva-pharmaceuticals-form-rd-alliance-cancer-dna-da... | CRT and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs |
/crt-institute-cancer-research-and-merck-serono-sign-wnt-lic... | CRT, The Institute of Cancer Research and Merck Serono sign WNT licensing deal |
/cruk-cambridge-institute-symposium | CRUK Cambridge Institute Symposium |
/cancer-research-uk-and-crt-collaborate-abcodia-discover-and... | Cancer Research UK and CRT collaborate with Abcodia to discover and develop tests for cancer |
/forma-therapeutics-and-crt-discover-cancer-drugs-targeting-... | FORMA Therapeutics and CRT to discover cancer drugs targeting deubiquitinating enzymes (DUBs) |
/new-board-appointment-crt | New board appointment for CRT |
/new-offices-crt | New offices for CRT |
/cruk-research-strategy-great-place-come-and-do-business | "This is a great place to come and do business" |
/2014-bio-international-convention | 2014 BIO International Convention |
/2014-medicinal-chemistry-gordon-research-conference | 2014 Medicinal Chemistry Gordon Research Conference |
/2014-year-review-infographic | 2014 Year in Review Infographic |
/2015-bio-international-convention | 2015 BIO International Convention |
/2016-bio-international-convention | 2016 BIO International Convention |
/26th-eortc-nci-aacr-symposium | 26th EORTC-NCI-AACR SYMPOSIUM |
/28th-eortc-nci-aacr-symposium | 28th EORTC-NCI-AACR Symposium |
/aacr-annual-meeting-2014 | AACR Annual Meeting |
/aacr-annual-meeting-2015 | AACR Annual Meeting 2015 |
/AACR2016 | AACR Annual Meeting 2016 |
/aacr-annual-meeting-2017 | AACR Annual Meeting 2017 |
/aacr-nci-eortc | AACR-NCI-EORTC 2015 |
/autm-2015-annual-meeting | AUTM 2015 Annual Meeting |
/AUTM2016 | AUTM 2016 Annual Meeting |
/academic-drug-discovery-workshop | Academic Drug Discovery Workshop |
/StructuralBiology2016 | Accelerator Structural Biology Conference 2016 |
/achilles-therapeutics-launched-funds-%C2%A3132-million-deve... | Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer |
/achilles-therapeutics-raises-%C2%A3100-million-oversubscrib... | Achilles Therapeutics raises £100 million in oversubscribed Series B financing |
/adaptate-biotherapeutics-formed-develop-antibody-based-ther... | Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells |
/alchemia-announces-licensing-fak-inhibitors-crt | Alchemia announces in-licensing of FAK inhibitors from CRT |
/aptamer-therapeutics-and-cancer-research-uk-announce-partne... | Aptamer Therapeutics and Cancer Research UK announce partnership for drug development programme |
/arxx-therapeutics-and-cancer-research-uk-announce-licence-a... | Arxx Therapeutics and Cancer Research UK announce license agreement |
/autolus-therapeutics-raised-1008-million | Autolus Therapeutics raised $100.8 million |
/azeria-therapeutics-announces-%C2%A3320-million-series-b-fi... | Azeria Therapeutics Announces £32.0 million Series B Financing |
/bacit-seeks-shareholder-approval-commit-%C2%A320m-and-join-... | BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner |
/balversa%E2%84%A2-gains-us-marketing-approval-following-ear... | BALVERSA(TM) gains US marketing approval following early discovery work funded by CRUK |
/bicycle-therapeutics-and-cancer-research-uk-named-best-part... | BICYCLE THERAPEUTICS AND CANCER RESEARCH UK NAMED BEST PARTNERSHIP ALLIANCE OF THE YEAR AT 2017 SCRIP AWARDS |
/BioSpring2016 | BIO-EUROPE SPRING 2016 |
/bio-europe-spring-2014 | BIO-Europe Spring 2014 |
/bicycle-therapeutics-and-cancer-research-uk-collaborate-dev... | Bicycle Therapeutics and Cancer Research UK to collaborate on development of new Bicycle® immuno-oncology candidate, BT7401 |
/bio-europe-autumn-2015 | Bio-Europe 2015 |
/bio-europe-autumn-2016 | Bio-Europe Autumn 2016 |
/bio-europe-spring-2017 | Bio-Europe Spring 2017 |
/bio-homecoming-2016 | Bio-Homecoming 2016 |
/bioinvents-bi-1206-antibody-enter-collaborative-trial | BioInvents BI-1206 antibody to enter collaborative Phase I/II trial |
/biowednesday-future-directions-oncology | BioWednesday: Future Directions in Oncology |
/biotech-and-money-london-2015 | Biotech and Money London 2015 |
/biotechs-and-city | Biotechs and the City |
/crt-highlighted-dowling-review-business-university-research... | CRT Highlighted in the Dowling Review of Business-University Research Collaborations |
/crt-pioneer-fund-banks-%C2%A320m-investment-bacit-and-expan... | CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics |
/crt-pioneer-fund-collaborates-chroma-therapeutics-develop-c... | CRT Pioneer Fund collaborates with Chroma Therapeutics |
/crt-pioneer-fund-bacit-and-sareum-enter-agreement-fund-deve... | CRT Pioneer Fund, BACIT and Sareum enter agreement |
/crt-pioneer-fund-cancer-research-uk-and-nci-collaborate-boo... | CRT Pioneer Fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS |
/crt-and-alta-innovations-join-forces-commercialise-world-le... | CRT and Alta Innovations join forces to commercialise world-leading research |
/crt-and-astrazeneca-expand-successful-multi-project-cancer-... | CRT and AstraZeneca expand successful multi-project cancer metabolism alliance |
/crt-and-bioinvent-expand-collaboration-university-southampt... | CRT and BioInvent expand collaboration with University of Southampton scientists |
/crt-and-sv-life-sciences-form-artios-pharma-focus-dna-damag... | CRT and SV life sciences form Artios Pharma to focus on DNA damage response |
/crt-and-tevas-collaboration-yields-successful-outcome | CRT and Teva’s collaboration yields successful outcome with novel aPKC protein inhibitor cancer drug discovery candidate |
/crt-and-icr-enter-collaboration-janssen-discover-multiple-m... | CRT and The ICR enter collaboration with Janssen to discover multiple myeloma drug |
/crt-and-university-copenhagen-announce-agreement-adc-therap... | CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer |
/crt-and-university-manchester-receive-success-payment-glaxo... | CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration |
/crt-announces-license-agreement-msd-develop-inhibitors-prmt... | CRT announces license agreement with MSD to develop inhibitors of PRMT5 for cancer and blood disorders |
/crt-drives-novel-and-collaborative-drug-discovery-areas-%C3... | CRT drives novel and collaborative drug discovery in areas of "hot" cancer science |
/crt-signs-agreement-cimass-development-monoclonal-antibody-... | CRT signs agreement with CiMass for the development of a monoclonal antibody in the treatment of cancer. |
/crt-unveils-screen-test-potential-drugs-treat-oestrogen-pos... | CRT unveils screen test for potential drugs to treat oestrogen positive breast cancer |
/crt-university-manchester-and-glaxosmithkline-work-together... | CRT, University of Manchester and GlaxoSmithKline work together to generate new cancer drugs |
/crt%E2%80%99s-discovery-laboratories-extends-alliance-merck... | CRT’s Discovery Laboratories extends alliance with Merck to develop new cancer drugs |
/cancer-research-uk-forms-collaboration-sv-health-investors-... | CRUK forms partnership with SV Health Investors in life sciences investment fund to accelerate development of cancer medicines |
/cancer-research-uk-cancer-research-technology-and-asterias-... | CRUK, CRT and Asterias Biotherapeutics partner to trial immunotherapy vaccine for lung cancer |
/call-small-molecules-tool-compounds | Call for Small Molecules as Tool Compounds |
/cancer-advance-harvard-med | Cancer Advance Harvard Med |
/cancer-drug-discovery-and-preclinical-development-summit | Cancer Drug Discovery and Preclinical Development Summit |
/cancer-research-technology-pioneer-fund-announces-investmen... | Cancer Research Technology Pioneer Fund announces investment in blood cancer drugs |
/cancer-research-technology-and-forma-therapeutics-excellent... | Cancer Research Technology and FORMA Therapeutics: An excellent marriage |
/cancer-research-technology-and-medivir-collaborate-develop-... | Cancer Research Technology and Medivir collaborate to develop new class of cancer drugs |
/cancer-research-technology-and-nuevolution-sign-multi-targe... | Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs |
/cancer-research-technology-and-pangaea-biotech-sign-license... | Cancer Research Technology and Pangaea Biotech sign license agreement for new cancer drugs |
/cancer-research-technology-appoints-deborah-harland-non-exe... | Cancer Research Technology appoints Deborah Harland as Non-Executive Director |
/cancer-research-technology-introduces-ximbio-online-reagent... | Cancer Research Technology introduces Ximbio, an online reagents portal |
/cancer-research-technology-ucl-and-tusk-therapeutics-join-f... | Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies |
/cancer-research-uk-and-bicycle-therapeutics-have-collaborat... | Cancer Research UK AND Bicycle Therapeutics have collaborated to trial new therapy for advanced solid tumours |
/cancer-research-uk-beatson-institute-starts-strategic-colla... | Cancer Research UK Beatson Institute starts strategic collaboration to accelerate KRAS drug discovery |
/cancer-research-uk-and-astrazeneca-launch-world-class-funct... | Cancer Research UK and AstraZeneca launch world class Functional Genomics Centre |
/cancer-research-uk-and-astrazeneca-sign-deal-repurpose-asth... | Cancer Research UK and AstraZeneca sign deal to repurpose asthma drug that could fight kidney cancer |
/cancer-research-uk-and-cancer-research-technology-announce-... | Cancer Research UK and Cancer Research Technology announce partnership with Monopar Therapeutics |
/cancer-research-uk-and-cancer-research-technology-join-forc... | Cancer Research UK and Cancer Research Technology join forces with Astellas on autophagy to find new cancer treatments |
/cancer-research-uk-and-cancer-research-technology-partner-t... | Cancer Research UK and Cancer Research Technology partner with TYG Oncology to develop next generation cancer vaccine |
/cancer-research-uk-and-hummingbird-bioscience-join-forces-a... | Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials |
/cancer-research-uk-and-leukaemia-lymphoma-research-team-boo... | Cancer Research UK and Leukaemia & Lymphoma Research team up to boost blood cancer trials |
/cancer-research-uk-and-medimmune-establish-joint-cruk-medi-... | Cancer Research UK and MedImmune establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines |
/cancer-research-uk-and-medimmune-launch-ground-breaking-bio... | Cancer Research UK and MedImmune launch ground-breaking biotherapeutics research centre in Cambridge |
/cancer-research-uk-and-newcastle-university-extend-successf... | Cancer Research UK and Newcastle University extend successful multi-project drug discovery alliance with Astex Pharmaceuticals |
/cancer-research-uk-and-institute-cancer-research-london-joi... | Cancer Research UK and the Institute of Cancer Research, London, join forces with Merck in new drug discovery alliance |
/cancer-research-uk-announces-drug-discovery-collaboration-c... | Cancer Research UK announces drug discovery collaboration with Celgene Corporation |
/cancer-research-uk-boost-entrepreneurs-science | Cancer Research UK boost entrepreneurs in science |
/cancer-research-uk-brings-commercialisation-arm-house | Cancer Research UK brings commercialisation arm in-house |
/cancer-research-uk-drug-launched-its-first-clinical-trial | Cancer Research UK drug launched in its first clinical trial |
/cancer-research-uk-collaborate-astrazeneca-screening-new-ca... | Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines |
/cancer-research-uk-crt-and-amgen-trial-leukaemia-immunother... | Cancer Research UK, CRT and Amgen to trial leukaemia immunotherapy drug in other cancers |
/cancer-research-uk-lifearc-and-ono-pharmas-immunotherapy-al... | Cancer Research UK, LifeArc and Ono Pharma's Immunotherapy Alliance wins Best Partnership Alliance at 2019 Scrip Awards |
/cancer-research-uk-lifearc-and-ono-pharma-form-cancer-immun... | Cancer Research UK, LifeArc and Ono Pharma form cancer immunotherapy alliance |
/cancer-research-uk-ono-pharmaceutical-and-lifearc-are-short... | Cancer Research UK, ONO Pharmaceutical and LifeArc are shortlisted for a Scrip Award |
/cancer-research-uk%E2%80%99s-interview-network-life-science... | Cancer Research UK’s interview with The Network for Life Science Executive Leaders |
/cancer-research-uk%E2%80%99s-license-and-collaboration-part... | Cancer Research UK’s license and collaboration partner Tusk Therapeutics, is acquired by Roche |
/consortium-signs-deal-basilea-develop-resistance-busting-ca... | Consortium signs deal with Basilea to develop resistance-busting cancer drugs |
/elrig-drug-discovery-2015 | ELRIG Drug Discovery 2015 |
/faseb-lipids-and-lipid-regulated-kinases-cancer | FASEB: Lipids and Lipid Regulated Kinases in Cancer |
/first-human-trial-new-lung-cancer-immunotherapy | First-in-human trial for new lung cancer immunotherapy |
/forma-therapeutics-and-crt-form-third-virtual-company-advan... | FORMA Therapeutics and CRT form a third virtual company to advance deubiquitination assets |
/forma-therapeutics-and-crt-form-two-virtual-companies-advan... | FORMA Therapeutics and CRT form two virtual companies to advance deubiquitination assets |
/gammadelta-therapeutics-raises-seed-funding-abingworth | GammaDelta Therapeutics Raises Seed Funding from Abingworth |
/glythera-licenses-novel-payload-class-cancer-research-uk-de... | Glythera licenses novel payload class from Cancer Research UK for the development of next-generation antibody drug conjugates |
/highlights-ncri-conference-2013 | Highlights from the NCRI Conference 2013 |
/hitgen-announces-collaboration-drug-discovery-university-ma... | HitGen Announces Collaboration in Drug Discovery |
/hitgen-and-cancer-research-uk%E2%80%99s-manchester-institut... | Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer |
/how-we-are-advancing-discoveries-beat-cancer | How we are advancing discoveries to beat cancer |
/inivata-completes-%C2%A3315-million-45m-series-fundraising-... | Inivata Completes £31.5 Million ($45M) Series A Fundraising Round |
/inivata-raises-%C2%A34m-realise-potential-ctdna-analysis-im... | Inivata Raises £4m to Realise the Potential of ctDNA Analysis to Improve Cancer Treatment Through Simple Blood Tests |
/inivata-completes-%C2%A3398-million-526m-series-b-round | Inivata completes £39.8 million ($52.6M) series B round |
/instinctif-partners-hosts-cancer-research-technology-event-... | Instinctif Partners hosts Cancer Research Technology event on innovative cancer diagnostics and treatments |
/international-deal-screen-potential-cancer-drugs-using-dna-... | International deal to screen potential cancer drugs using DNA 'barcodes' |
/major-drug-discovery-feasibility-study-merck-serono | MAJOR DRUG DISCOVERY FEASIBILITY STUDY WITH MERCK SERONO |
/mission-therapeutics-raises-%C2%A360-million-progress-devel... | MISSION Therapeutics raises £60 million to progress development of novel DUB inhibitors from innovative drug platform |
/mrc-technology-cancer-research-uk-and-cancer-research-techn... | MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies |
/merck-ventures-creates-new-immuno-oncology-company-ionctura | Merck Ventures Creates New Immuno-Oncology Company iOnctura |
/metastasis | Metastasis Workshop 2015 |
/ncri-cancer-conference-2014 | NCRI Cancer Conference 2014 |
/ncri-cancer-conference-2015 | NCRI Cancer Conference 2015 |
/ncri-cancer-conference-2016 | NCRI Cancer Conference 2016 |
/nemucore-medical-innovations-options-clinical-stage-aurora-... | Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From CRT |
/networking-top-luncheon | Networking at the Top Luncheon |
/catapult | New collaboration for CAR-T cell immuno-oncology therapy development |
/new-offices-crt-inc | New offices for CRT Inc. |
/helix-2014 | ON Helix 2014 |
/pdx-models-workshop-2014 | PDX Models Workshop 2014 |
/pdx-workshop | PDX Workshop |
/preclinical-models-network-taking-shape | Preclinical models network taking shape |
/crt-pioneer-fund-licenses-oncology-drug-targeting-dna-damag... | ProNAi Licenses Oncology Drug Targeting DNA Damage Response Checkpoint Kinase 1 (Chk1) from CRT Pioneer Fund |
/promising-results-phase-1-trial-lead-immatics-continue-work... | Promising results in Phase 1 trial lead immatics to continue work on vaccine (IMA950) for glioblastoma |
/rd-alliance-restructure-presents-new-dna-damage-response-pa... | R&D alliance restructure presents new DNA damage response partnership opportunities including leading PolQ project |
/Sachs | Sachs 15th Annual Biotech in Europe Forum |
/scancell-and-cancer-research-uk-collaborate-advance-novel-c... | Scancell and Cancer Research UK collaborate to advance novel cancer immunotherapy into clinical trials |
/stemline-therapeutics-obtains-worldwide-rights-novel-select... | Stemline Therapeutics obtains worldwide rights to novel selective RET inhibitor |
/storm-therapeutics-secures-%C2%A312m-investment-cancer-ther... | Storm Therapeutics secures £12m investment for cancer therapeutics |
/success-all-round-cancer-research-uk-supported-spinouts-obn... | Success all round for CRUK supported spinouts at the OBN annual awards |
/successful-completion-phase-i-trial-gsk1070916 | Successful completion of the Phase I trial of GSK1070916 |
/takeda-and-gammadelta-therapeutics-announce-collaboration-a... | Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells |
/crt-pioneer-fund-and-cancer-research-uk%E2%80%99s-mancheste... | The CRT Pioneer Fund and Cancer Research UK’s Manchester Institute nominate cancer drug candidate |
/cancer-research-uk-innovation-summit | The Cancer Research UK Innovation Summit |
/three-new-companies-join-cancer-research-uk-abcodia-collabo... | Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection |
/tumour-analysis-following-surgery-could-provide-breakthroug... | Tumour analysis following surgery could provide breakthrough in predicting how well cancer patients respond to drug treatment |
/two-cancer-research-technology-deals-shortlisted-leading-in... | Two Cancer Research Technology deals shortlisted for leading industry awards |
/ucl%E2%80%99s-cancer-immunology-group-publishes-relevance-c... | UCL’s Cancer Immunology group publishes on the relevance of CD25 as a target in cancer |
/valneva-and-blink-therapeutics-confirm-launch-and-funding-b... | Valneva and BliNK Therapeutics confirm launch and funding of BliNK Biomedical |
/world-pharma-licensing-congress-2014 | World Pharma Licensing Congress 2014 |
/%C2%A350m-crt-pioneer-fund-announces-investment-develop-lun... | £50M CRT Pioneer Fund announces invest to develop lung cancer drugs at Cancer Research UK's Manchester Institute |
/carrick-therapeutics-licenses-targeted-ovarian-cancer-treat... | Carrick Therapeutics in-licenses targeted ovarian cancer treatment discovered at the ICR |
/careers | Careers |
/vacancies | Current Vacancies |
/contact-us | Contact Us |
/node?qt-front_page_tabs=0#qt-front_page_tabs | LATEST NEWS |
/node?qt-front_page_tabs=1#qt-front_page_tabs | EVENTS |
/node?qt-front_page_tabs=2#qt-front_page_tabs | |
news-and-events?qt-news_tabs=3#qt-news_tabs | View upcoming events |
/our-company | About |
/licensing-opportunites | Licensing Opportunities |
/terms-conditions | Terms & Conditions |
/legal-status | Legal Status |
/cookie-policy | Click here |
[Querying whois.verisign-grs.com]
[Redirected to whois.melbourneit.com]
[Querying whois.melbourneit.com]
[whois.melbourneit.com]
Domain Name.......... cancertechnology.com
Creation Date........ 2002-09-09
Registration Date.... 2004-09-01
Expiry Date.......... 2017-09-09
Organisation Name.... Cancer Research Technology Limited
Organisation Address. Sardinia House
Organisation Address. Sardinia Street
Organisation Address.
Organisation Address. London
Organisation Address. wc2a 3nl
Organisation Address. -
Organisation Address. GREAT BRITAIN (UK)
Admin Name........... Compulink Information Exchange Ltd
Admin Address........ Carlton House
Admin Address........ 27a Carlton Drive
Admin Address........
Admin Address. Putney
Admin Address........ SW15 2BS
Admin Address........ London
Admin Address........ GREAT BRITAIN (UK)
Admin Email.......... hostmaster@gxn.net
Admin Phone.......... +44.02089571000
Admin Fax............ +44.02089571060
Tech Name............ Technical Department
Tech Address......... Langlands House
Tech Address......... Sandringham Avenue
Tech Address.........
Tech Address......... Harlow
Tech Address......... CM19 5QA
Tech Address......... Essex
Tech Address......... GREAT BRITAIN (UK)
Tech Email........... technical@globalgold.co.uk
Tech Phone........... +44.8702844444
Tech Fax............. +44.8702844450
Name Server.......... ns2.globalgold.co.uk
Name Server.......... ns3.globalgold.co.uk
Name Server.......... ns1.globalgold.co.uk
США - 165.112.1.20
National Institutes of Health
National Institutes of Health
HTTP/1.1 200 OK
Server: nginx
Date: Mon, 13 Jan 2020 01:37:32 GMT
Content-Type: text/html; charset=utf-8
X-Drupal-Cache: MISS
X-Content-Type-Options: nosniff
Content-Language: en
X-Frame-Options: SAMEORIGIN
Cache-Control: public, max-age=3600
Last-Modified: Mon, 13 Jan 2020 01:37:32 GMT
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Vary: Cookie,Accept-Encoding
X-Request-ID: v-444e3aa8-35a5-11ea-83de-22000a55af8f
X-AH-Environment: prod
Age: 2391
ETag: W/"1578879452-1"
Via: varnish
X-Cache: HIT
X-Cache-Hits: 46
Accept-Ranges: bytes
Content-Length: 128536
Connection: keep-alive
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"